Additional Reading
- More on the web
- 2007
- 2005
- 2004
- 2001
- 2000
- 1999
- 1998
- 1997
- 1995
Thrombosis Clinical Center, Department of Medicine (Hematology & Oncology), Presbyterian Hospital of Dallas, Tex., USA.
Once you have achieved a pregnancy that results in either an arrested pregnancy or a spontaneous abortion it is wise to undergo immune testing to determine whether there is an underlying immunological condition preventing the pregnancy from continuing. Testing is recommended for those couples that have undergone multiple IVF cycles without success.
In addition the couple should be tested for HLA compatibility, also known as DQ-Alpha testing. This determines whether the couple is so similar that the female’s immune system does not produce protective antibodies to protect the fetus because her body does not recognize the cells arising from her partner as foreign. The treatment for this condition is Lymphocyte Immune Therapy or LIT. This is a paternal white blood cell immunization from the male to the female. This helps to stimulate the protective antibody reaction. The immunization is done subcutaneously on the forearm of the female partner. This is usually repeated at the time of a positive pregnancy test.
Note: as of January 2002 the US FDA has put a suspension on LIT treatment to determine its efficacy. Contact the Beer Clinic for further instructions, which most likely will include IVIG treatment (see below).
There are other blood components that can cause problems but if the above treatment is followed the combined effort is usually enough to combat the remaining components. The treatment is successful 75-85% of the time depending on the combination of problems. But sometimes the female partner has cells in her body that attack the fetus independent of the other antibodies. These cells are called Natural Killer Cells, CD 56+, and CD 19+5+ cells.
In the event that these cells are present in higher than normal limits, there is a treatment outlined in the reading material known as IVIG. This is very successful but can cause unpleasant side-effects, the most common one being a migraine headache that can last 24 hours. Not all patients can tolerate it. This therapy is usually used in conjunction with LIT. The IVIG product that is used by The Beer Clinic is detergent treated. This product, Venaglobin S, has been in use without incident for over 15 years. There are other products on the market but are not as safe as this one.
At this time the only reliable place to do the entire immunological workup and have the Lymphocyte Immune Therapy and/or IVIG in the US is
15195 National Ave #202
Los Gatos, CA 95032, USA
Phone: (408) 356-9500
(408) 356-9509
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
www.repro-med.net
At the Beer Clinic, you can see either Dr. Trobough or Dr. Stricker. You can send them your blood for testing to see if the LIT or IVIG is necessary. You may not need to physically go there. They will send you a letter outlining your personal protocol (recipe for success) and if you do not require LIT or IVIG you can just have your doctor prescribe the other medications. The Beer Clinic may recommend follow-up blood tests so that they can monitor your progress and adjust your protocol. In Canada, IVIG is available at various centers where a study is being done to determine its effectiveness.
Contact me for further information if you are Canadian.
Recurrent miscarriage is a complex and controversial issue but it can be successfully treated step by step. First, if you can get pregnant naturally you are halfway there. If you cannot get pregnant without assisted reproductive technology you must attack your problem on two fronts. You must see the issue as having
Physical complications of pregnancy can be overcome through the use of a variety of assisted reproductive techniques.
Dr. William H. Kutteh, M.D., Ph.D.
Dr. Kutteh is Director of Fertility Associates of Memphis and board-certified in Reproductive Endocrinology and Infertility. Dr Kutteh is also Laboratory Director for Memphis Fertility Laboratory, Inc. and Reproductive Laboratory, Inc. In addition to Reproductive Endocrinology, Dr. Kutteh is also board-certified in Obstetrics and Gynecology and Immunology. He is the author of more than 200 publications and has lectured internationally in his field. He is a member of the American Society for Reproductive Medicine where has presented courses on Recurrent Pregnancy Loss among others. Dr. Kutteh has been named one of America’s Top Obstetricians and Gynecologists each year since 2002, a Best Doctor in America annually since 2001, and one of Memphis’ Best Doctors each year since 1999.
The Alan E. Beer Center for Reproductive Immunology & Genetics
The Alan E. Beer Center for Reproductive Immunology & Genetics researches and treats couples who experience recurrent miscarriages, multiple pregnancy losses or repeated in vitro fertilization failures. They offer comprehensive testing and boast an 85% success rate in achieving successful pregnancies for these couples.
Inflammatory Effector Mechanisms Laboratory, Dr. Jane Salmon
Dr. Salmon is Professor of Medicine and Professor of Obstetrics and Gynecology at Weill Medical College and the Collette Kean Research Professor at Hospital for Special Surgery.
Dr. Mary Stephenson
Dr. Stephenson is an internationally renown expert in the treatment of recurrent miscarriage. She is the Director of the Recurrent Pregnancy Loss Program at University of Chicago.
SHER Institutes for Reproductive Medicine
Specializing in the diagnosis and treatment of Immunologic Implantation Failure.
Recurrent Miscarriage: causes, evaluation, and treatment
Medscape Women’s Health 1998 May;3(3):2 (ISSN: 1521-2076)
Relationship to spontaneous abortion Role of Chromosomal Anomalies in Recurrent Spontaneous Abortion |
Links to Web Sites with More Information
Gene Tied to Late Miscarriage
By Carolyn Abraham - Globe and Mail
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.
Girardi G, Redecha P, Salmon JE.
Scientists on Trail of Miscarriage Mystery
By Luma Muhtadie - Globe and Mail
Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin
Am J Reprod Immunol 2001 Mar;45(3):174-9 (ISSN: 1046-7408)
Is the paternal mononuclear cells' immunization a successful treatment for recurrent spontaneous abortion?
Am J Reprod Immunol 2000 Sep;44(3):129-35 (ISSN: 1046-7408)
The use of intravenous immunoglobulin in sine causa or alloimmune recurrent spontaneous abortion (RSA)
Panminerva Med 2000 Sep;42(3):193-5 (ISSN: 0031-0808)
Pregnancy after four recurrent pregnancy losses: a case report
Ginekol Pol 2000 Jun;71(6):536-41 (ISSN: 0017-0011)
Effects of paternal lymphocyte immunization on peripheral Th1/Th2 balance and TCR V beta and V gamma repertoire usage of patients with recurrent spontaneous abortions
Am J Reprod Immunol 2000 Feb;43(2):107-15 (ISSN: 1046-7408)
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin
Br J Obstet Gynaecol 1999 Feb;106(2):102-7 (ISSN: 0306-5456)
Is there a role for antithrombotic therapy in the prevention of pregnancy loss?
Haemostasis 1999 Dec;29 Suppl S1:112-20 (ISSN: 0301-0147)
Habitual abortions in 678 healthy patients: investigation and prevention
Hum Reprod 1999 Aug;14(8):2106-9 (ISSN: 0268-1161)
Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review
Scand J Rheumatol Suppl 1998;107:97-102 (ISSN: 0301-3847)
Re-evaluation of immunomodulator treatments for recurrent abortions
Rev Med Brux 1998 Apr;19(2):69-72 (ISSN: 0035-3639)
Immunotherapy before and during pregnancy improves pregnancy outcome in women who suffer from recurrent abortion and did not benefit from immunotherapy before pregnancy
Am J Reprod Immunol 1998 Jan;39(1):12-5 (ISSN: 1046-7408)
Recurrent fetal death and antiphospholipid antibody syndrome: A case report
Ginecol Obstet Mex 1997 Dec;65:523-8 (ISSN: 0300-9041)
Antiphospholipid antibodies, infertility and recurrent miscarriage
Curr Opin Obstet Gynecol 1997 Aug;9(4):279-82 (ISSN: 1040-872X)
Clinical and immunological condition of newborns of mothers treated for recurrent spontaneous abortions with paternal lymphocytes immunization
Eur J Obstet Gynecol Reprod Biol 1997 May;73(1):55-61 (ISSN: 0301-2115)
Immunotherapy for recurrent spontaneous abortion.
Early Pregnancy 1995 Mar;1(1):13-26 (ISSN: 1354-4195)